SRD Signs Agreement With OmniComm
FORT LAUDERDALE, FL, Aug. 09, 2017 (GLOBE NEWSWIRE) - OmniComm Systems, Inc., a global provider of clinical data management technology, has a new technology partner in Japan. SRD Co., Ltd., a contract research organization (CRO) in Tokyo, has selected OmniComm’s TrialMaster electronic data capture (EDC) technology to support clinical trial research for pharmaceutical, medical devices, and related healthcare products. The agreement represents the first contract for TrialMaster in Japan.
“SRD selected TrialMaster EDC because it offers efficient and easy support, and provides site users with easy-to-use data entry screens that support high-quality data capture and avoid unnecessary system-generated queries,” said Akira Sugihara, general manager of SRD’s data science department. “In addition, OmniComm provides excellent support-in the local language-for our study-build activities, operational challenges and our business development activities.”
TrialMaster was selected for its speed of study build, flexibility, multilingual capabilities, and its ability to both transpose data and export data in SDTM format directly from the EDC solution. Some TrialMaster features include: real-time edit checks, real-time reporting, and the ability to customize data exports. OmniComm’s technology transition deployment model, which allows customers to build their studies while OmniComm manages the hosting in its data centers, was another factor in the selection process.
“We started preparing to bring TrialMaster to the Japanese market in 2016. In Japan, more so than any other country, it requires not only a superior product, but above all, endurance and focus to bring a new technology to the market and secure your first customers,” said Wolf Ondracek, senior vice president at OmniComm, with responsibility for the Asia-Pacific region. “The fact that SRD, a local Japanese CRO, has chosen TrialMaster as its EDC system for industry-sponsored trials is a tremendously important milestone. I am confident that it marks the start of the successful penetration of the Japanese market for our flagship EDC solution, TrialMaster.”
Contact Info
Kuno van der Post
OmniComm Systems, Inc.
+1.954.473.1254
KVanderPost@omnicomm.com
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
